Ionis Pharmaceuticals IONS Patent Expenses
Patent Expenses at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:PatentExpenses.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's patent expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's patent expenses?
- Ionis Pharmaceuticals (IONS) reported patent expenses of $1.6M in Q4 2025.
- How has Ionis Pharmaceuticals's patent expenses changed year-over-year?
- Ionis Pharmaceuticals's patent expenses increased by 20.8% year-over-year, from $1.33M to $1.6M.
- What is the long-term trend for Ionis Pharmaceuticals's patent expenses?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's patent expenses has grown at a 22.0% compound annual growth rate (CAGR), from $4.3M to $6.4M.
- What does patent expenses mean?
- The costs associated with obtaining and protecting patents for the company's inventions.
- How do you interpret patent expenses?
- An increase may signal a ramp-up in R&D output or defensive legal activity, while a decrease could indicate a reduction in pipeline breadth.
- How does patent expenses compare across companies?
- Standard operating expense for R&D-heavy companies; peers typically disclose this as part of SG&A or R&D overhead.